Browse by UCL Departments and Centres
Group by: Author | Type
Number of items: 6.
A
Ahmed, F;
Ings, SJ;
Pizzey, AR;
Blundell, MP;
Thrasher, AJ;
Ye, HT;
Fahey, A;
... Yong, KL; + view all
(2004)
Impaired bone marrow homing of cytokine-activated CD34<sup>+</sup> cells in the NOD/SCID model.
Blood
, 103
(6)
pp. 2079-2087.
10.1182/blood-2003-06-1770.
|
Andre, T;
Boni, C;
Mounedji-Boudiaf, L;
Navarro, M;
Tabernero, J;
Hickish, T;
Topham, C;
... de Gramont, A; + view all
(2004)
Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.
NEW ENGLAND JOURNAL OF MEDICINE
, 350
(23)
pp. 2343-2351.
10.1056/NEJMoa032709.
|
Aubert, G.;
(2004)
Molecular detection, monitoring and modulation of antigen specific immune responses.
Doctoral thesis , University of London.
|
J
Jakupovic, I.;
Grandage, V.L.;
Linch, D.C.;
Khwaja, A.;
(2004)
Lack of effect of the human GM-CSF analog E21R on the survival of primary human acute myeloid leukemia cells.
Blood
, 103
(8)
pp. 3230-3232.
10.1182/blood-2003-06-1985.
|
Jones, DT;
Addison, E;
North, JM;
Lowdell, MW;
Hoffbrand, AV;
Mehta, AB;
Ganeshaguru, K;
... Wickremasinghe, RG; + view all
(2004)
Geldanamycin and herbimycin A induce apoptotic killing of B chronic lymphocytic leukemia cells and augment the cells' sensitivity to cytotoxic drugs.
Blood
, 103
(5)
pp. 1855-1861.
10.1182/blood-2003-05-1603.
|
M
Morris, E.;
Thomson, K.;
Craddock, C.;
Mahendra, P.;
Milligan, D.;
Cook, G.;
Smith, G.M.;
... Mackinnon, S.; + view all
(2004)
Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma.
Blood
, 104
(13)
pp. 3865-3871.
10.1182/blood-2004-03-1105.
|